BioCentury
ARTICLE | Clinical News

EndoBarrier Gastrointestinal Liner regulatory update

January 4, 2010 8:00 AM UTC

GI Dynamics received CE Mark approval in the EU for its EndoBarrier Gastrointestinal Liner to treat obesity and Type II diabetes. The company plans to launch the 60 cm-liner, which is non-surgically p...